BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35794062)

  • 1. Waiting time for Mohs Micrographic Surgery and the associated increase in lesion size of basal cell carcinoma.
    Kokkinos C; Kanapathy M; Heydari S; Hamilton S; Withey S
    J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3384-3389. PubMed ID: 35794062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin.
    Diehl J; Choi YM; Liang LJ; Chiu M
    Dermatol Surg; 2015 Jul; 41(7):768-74. PubMed ID: 26050214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
    van Kester MS; Goeman JJ; Genders RE
    J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using optical coherence tomography to optimize Mohs micrographic surgery.
    Akella SS; Lee J; May JR; Puyana C; Kravets S; Dimitropolous V; Tsoukas M; Manwar R; Avanaki K
    Sci Rep; 2024 Apr; 14(1):8900. PubMed ID: 38632358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
    Litwin AS; Rytina E; Ha T; René C; Woodruff SA
    J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult-to-treat basal cell carcinoma: a retrospective clinical study.
    Yu N; Wu L; Su J; Chen M; Lu L; Huang K; Li Y; Jiang Z; Liu S; Peng L; Xie Y; Chen Z; Zhou W; Wan M; Fang F; Bu W; Zhao S
    J Dermatolog Treat; 2023 Dec; 34(1):2200871. PubMed ID: 37036184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
    Calvão J; Pinho A; Brinca A; Vieira R
    An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
    Català A; Garces JR; Alegre M; Gich IJ; Puig L
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
    Sin CW; Barua A; Cook A
    Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.
    Delgado Jiménez Y; Camarero-Mulas C; Sanmartín-Jiménez O; Garcés JR; Rodríguez-Prieto MÃ; Alonso-Alonso T; Miñano Medrano R; López-Estebaranz JL; de Eusebio Murillo E; Redondo P; Ciudad-Blanco C; Toll A; Artola Igarza JL; Allende Markixana I; Suarez Fernández R; Alfaro Rubio A; Alonso Pacheco ML; Vázquez-Veiga H; de la Cueva Dobao P; Ruiz-Salas V; Vilarrasa E; Barchino L; Morales-Gordillo V; Ocerin-Guerra I; Navarro Tejedor R; Hueso L; Mayor Arenal M; Seoane-Pose MJ; Cano-Martinez N; Garcia-Doval I; Descalzo MA;
    Int J Dermatol; 2018 Nov; 57(11):1375-1381. PubMed ID: 30246444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
    Lim GF; Perez OA; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
    Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
    Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma.
    Brown AC; Brindley L; Hunt WTN; Earp EM; Veitch D; Mortimer NJ; Salmon PJM; Wernham A
    Clin Exp Dermatol; 2022 Oct; 47(10):1794-1804. PubMed ID: 35596540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
    Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
    Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
    Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
    Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.